Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug concentration at the site of disease in children with pulmonary tuberculosis

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac103Source: DataRank Database

Drug concentration at the site of disease in children with pulmonary tuberculosis is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.58)OA: hybridTopics (95)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Ahmed A. Abulfathi ORCID,Natasha Strydom ORCID,Pierre Goussard ORCID,Abraham C. van Wyk ORCID,Anne Marie Demers

Live enrichment

PubMed:35468189 PMC:PMC9155609 OpenAlex:https://openalex.org/W4221055961

Spanish Ministry of Science and Innovation and State Research Agency

Grant: CEX2018-000806-S

EDCTP

Grant: TRIA.2015.1102

DFID

Grant: MR/R007942/1

Correlates of risk in children exposed to multidrug-resistant tuberculosis

NIAID NIH HHS

Grant: UM1 AI106716

National Institutes of Health

Grant: 5UM1AI106716-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center

Generalitat de Catalunya

Spanish Paediatrics Association

AEP

NIH

South African National Research Foundation

NIAID

Medical Research Council

FWCI

0.58

Citation Percentile

0.6%

Citation Trend

2022

2024

2025

hybridLicense: cc-by-nc

journalhttps://academic.oup.com/jac/article-pdf/77/6/1710/43893313/dkac103.pdf

publisherhttps://academic.oup.com/jac/article-pdf/77/6/1710/43893313/dkac103.pdf

journalhttps://doi.org/10.1093/jac/dkac103

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35468189

repositoryhttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485922

Fields of Study

Tuberculosis Research and EpidemiologyPharmaceutical studies and practicesPneumonia and Respiratory Infections0303 health sciences03 medical and health sciences

MeSH Terms

AdultAntitubercular AgentsChildEthambutolHumansInfantIsoniazidPyrazinamideSouth AfricaTuberculosis, Pulmonary

Keywords

MedicinePyrazinamideEthambutolIsoniazidRifampicinTuberculosisDrugPharmacokineticsLymphLymph nodeLungInternal medicineSurgeryPathologyPharmacologyAntitubercular AgentsClinical Pharmacy - Radboud University Medical CenterEthambutol (mesh)Lung (rcdc)Pharmaceutical SciencesSouth Africa1108 Medical Microbiology0605 Microbiology (for)Pharmacology & Pharmacy32 Biomedical and Clinical Sciences (for-2020)ChildPyrazinamide (mesh)Original ResearchPediatricHumans (mesh)3 Good Health and Well Being (sdg)South Africa (mesh)MIC DISTRIBUTIONSPulmonaryPharmacology and Pharmaceutical SciencesPOPULATION PHARMACOKINETICSFarmakologi och toxikologiVARIABILITYInfectious DiseasesMedical Microbiology6.1 PharmaceuticalsMYCOBACTERIUM-TUBERCULOSIS1115 Pharmacology and Pharmaceutical SciencesAntitubercular Agents (mesh)Life Sciences & Biomedicine0605 MicrobiologyAdultClinical SciencesChild (mesh)610Pharmacology and ToxicologyMicrobiologyEmerging Infectious Diseases (rcdc)Rare Diseases (rcdc)Rare DiseasesIsoniazid (mesh)HumansPediatric (rcdc)Tuberculosis, Pulmonary3202 Clinical Sciences (for-2020)RIFAMPINScience & Technology6.1 Pharmaceuticals (hrcs-rac)Biomedical and Clinical Sciences1115 Pharmacology and Pharmaceutical Sciences (for)1108 Medical Microbiology (for)InfantInfant (mesh)Farmaceutiska vetenskaperEmerging Infectious DiseasesOrphan DrugGood Health and Well BeingInfectious Diseases (rcdc)Microbiology (science-metrix)Orphan Drug (rcdc)Adult (mesh)Pulmonary (mesh)Tuberculosis (rcdc)3214 Pharmacology and pharmaceutical sciences (for-2020)Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being